The National Cancer Institute approved the following clinical research studies last month. For further information, contact the principal investigator listed. Phase I – 10449 A Phase 1 Study of ZEN003694 in Combination with Binimetinib in Solid Tumors with RAS Pathway Alterations and Triple Negative Breast Cancer University of Texas MD Anderson Cancer Center LAOPiha-Paul,...
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
